These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 4302959)

  • 41. Different antiviral activity and cell specificity of interferon preparations produced by mouse peritoneal cells at 37 degrees C and at 26 degrees C.
    Cembrzyńska-Nowak M
    Arch Immunol Ther Exp (Warsz); 1989; 37(5-6):499-502. PubMed ID: 2484831
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antiviral activity of bovine interferons on primate cells.
    Tovey MG; Bandu MT; Begon-Lours J; Brouty-Boyé D; Gresser I
    J Gen Virol; 1977 Aug; 36(2):341-4. PubMed ID: 197203
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Simultaneous viral and non-viral interferon production in human cell cultures.
    Bausek GH; Merigan TC
    Proc Soc Exp Biol Med; 1970 Mar; 133(3):982-5. PubMed ID: 5435593
    [No Abstract]   [Full Text] [Related]  

  • 44. Investigations on interferon induced by statolon.
    Kleinschmidt WJ; Murphy EB
    Virology; 1965 Dec; 27(4):484-9. PubMed ID: 4285373
    [No Abstract]   [Full Text] [Related]  

  • 45. Induction of the interferon mechanism by single-stranded RNA: potentiation by polybasic substances.
    Billiau A; Buckler CE; Dianzani F; Uhlendorf C; Baron S
    Proc Soc Exp Biol Med; 1969 Nov; 132(2):790-6. PubMed ID: 4311213
    [No Abstract]   [Full Text] [Related]  

  • 46. Enhancement of interferon production of murine peritoneal leukocytes by mineral oil: the effect of experimental EMC infection in mice.
    Mendelson J; Dick V
    Can J Microbiol; 1973 Apr; 19(4):544-6. PubMed ID: 4349471
    [No Abstract]   [Full Text] [Related]  

  • 47. Mengovirus-induced cytopathic effect in L-cells: protective effect of interferon.
    Haase AT; Levy H; Baron S; Kasel JA
    J Virol; 1969 Oct; 4(4):490-5. PubMed ID: 4309883
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interferon tolerance and antiviral protection in mice given single or multiple injections of endotoxin or poly I : C.
    Giron DJ; Schmidt JP; Pindak FF; Connell JE
    Acta Virol; 1973 May; 17(3):209-14. PubMed ID: 4147139
    [No Abstract]   [Full Text] [Related]  

  • 49. Interferon-sepharose: priming of L cells for induction of interferon by MM virus.
    Knight E
    J Gen Virol; 1974 Oct; 25(1):143-5. PubMed ID: 4372309
    [No Abstract]   [Full Text] [Related]  

  • 50. Interferon and cell division. V. Titration of the anticellular action of interferon preparations.
    Gresser I; Thomas MT; Brouty-Boyé D; Macieira-Coelho A
    Proc Soc Exp Biol Med; 1971 Sep; 137(4):1258-61. PubMed ID: 4333094
    [No Abstract]   [Full Text] [Related]  

  • 51. [Characteristics of the interactions of viruses and cells in chronically infected cultures].
    Andzhaparidze OG; Bogomolova NN
    Vopr Virusol; 1973; 18(6):643-9. PubMed ID: 4364045
    [No Abstract]   [Full Text] [Related]  

  • 52. The in vitro effect of cyclophosphamide on Col. MM virus replication and interferon production.
    Szalaty H; Golubska B
    Acta Microbiol Pol A; 1973; 5(3):176-80. PubMed ID: 4358716
    [No Abstract]   [Full Text] [Related]  

  • 53. Pronounced antiviral activity of human interferon on bovine and porcine cells.
    Gresser I; Bandu MT; Brouty-boye D; Tovey M
    Nature; 1974 Oct; 251(5475):543-5. PubMed ID: 4371444
    [No Abstract]   [Full Text] [Related]  

  • 54. The effect of an interferon inducer on influenza virus.
    Hill DA; Baron S; Chanock RM
    Bull World Health Organ; 1969; 41(3):689-93. PubMed ID: 4314307
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The biological properties of virus-induced and mitogen-induced interferons in dogs].
    Georgadze II; Orlova TG; Topuriia NV
    Vopr Virusol; 1991; 36(1):64-6. PubMed ID: 1713375
    [No Abstract]   [Full Text] [Related]  

  • 56. [Action of human leukocyte and immune interferons on the reproduction and cytopathogenic effect of the encephalomyocarditis virus in mice].
    Mentkevich LM; Zhdanova LV; Meshkova EN
    Vopr Virusol; 1984; 29(5):582-5. PubMed ID: 6097046
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Destruction of L cells by Mengo virus: use of interferon to study the mechanism.
    Gauntt CJ; Lockart RZ
    J Virol; 1968 Jun; 2(6):567-75. PubMed ID: 4301505
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antiviral activity of limitin against encephalomyocarditis virus, herpes simplex virus, and mouse hepatitis virus: diverse requirements by limitin and alpha interferon for interferon regulatory factor 1.
    Kawamoto S; Oritani K; Asada H; Takahashi I; Ishikawa J; Yoshida H; Yamada M; Ishida N; Ujiie H; Masaie H; Tomiyama Y; Matsuzawa Y
    J Virol; 2003 Sep; 77(17):9622-31. PubMed ID: 12915574
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Human interferon suppression of retrovirus production and cell fusion, and failure to inhibit replication of encephalomyocarditis virus in rhabdomyosarcoma (RD114) cells.
    Tomita Y; Nishimaki J; Takahashi F; Kuwata T
    Virology; 1982 Jul; 120(1):258-63. PubMed ID: 6179291
    [No Abstract]   [Full Text] [Related]  

  • 60. Enhancement of antiviral protection against encephalomyocarditis virus by a combination of isoprinosine and interferon.
    Chany C; Cerutti I
    Arch Virol; 1977; 55(3):225-31. PubMed ID: 74245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.